Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and Surveillance

Abstract excerpt

Bladder cancer is a prevalent malignancy with high mobility and mortality, particularly when diagnosed at an advanced stage. Early detection is critical, as it significantly improves prognosis and the patient's outcome. Bladder cancer also has a high recurrence rate, necessitating long-term surveillance. While cystoscopy remains the gold standard for diagnosis and monitoring. It is invasive and costly. Urine...

Topics

Open a Topic to create a Post that cites this publication.

• Carcinoma
• Cytological Techniques
• Disease Management
• Early Detection of Cancer
• Epigenomics
• Metabolomics
• Molecular Diagnostic Techniques
• Neoplasm Recurrence, Local

Identifiers and source

Literature Corpus work

31b48bd7-f306-55e0-bc1c-9ad2137dbfec

DOI

10.20944/preprints202510.0625.v1